共 8 条
[2]
A randomized, double‐blind, placebo‐controlled trial of tegaserod in female patients suffering from irritable bowel syndrome with constipation[J] . J.Novick,P.Miner,R.Krause,K.Glebas,H.Bliesath,G.Ligozio,P.Rüegg,M.Lefkowitz.Alimentary Pharmacology & Therapeutics . 2002 (11)
[3]
Rectal distention testing in patients with irritable bowel syndrome: Sensitivity, specificity, and predictive values of pain sensory thresholds[J] . Mickael Bouin,Victor Plourde,Michel Boivin,Monique Riberdy,France Lupien,Marie Laganière,Pierre Verrier,Pierre Poitras.Gastroenterology . 2002 (7)
[6]
Differences in expression of oligosaccharides, neuropeptides, carbonic anhydrase and neurofilament in rat primary afferent neurons retrogradely labelled via skin, muscle or visceral nerves[J] . M.J Perry,S.N Lawson.Neuroscience . 1998 (1)
[8]
Tegaserod, a 5-HT(4) receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating and constipation. Muller-Lissner SA,Fumagalli I,Bardhan KD, et al. Alimentary Pharmacology and Therapeutics . 2001